Biocytogen Boston Corp

Waltham, MA

UEI
SN23DNZQQTF9
CAGE
9FYY0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
300 3rd Ave FL 6, Waltham, MA 02451, USA
Website
biocytogen.com
Founded
2009
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Biocytogen Boston Corp's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
This firm fixed price purchase order is awarded for specialized knock-in mouse models to biocytogen boston… Contract · 75N94025P00385 National Institute of Child Health and Human Development $44,320
Biocytogen boston corp:1375719 [24-004703]DR. Harvey requires 0820014 custom RAT crispr KO in order to use services… Contract · 75N95024P00555 National Institute on Drug Abuse $24,999
Biocytogen boston corp:1375719 24-001992 FOS-T2A-ICREERT2 knockin sprague dawley RAT Contract · 75N95024P00155 National Institute on Drug Abuse $13,100
Knock out mouse pair services Contract · 36C24E23P0109 Veterans Integrated Service Network 4 $20,000
B-HIL2RA mice (110066) license Contract · 75N91023P00848 National Cancer Institute $24,000

About Biocytogen Boston Corp

Biocytogen Boston Corp is a for-profit, tax-exempt corporate entity specializing in genetically engineered animal models and scientific research services. Located in Waltham, Massachusetts, the company focuses on developing advanced transgenic and knockout animal models for biomedical research purposes. The organization is registered in SAM.gov and has been actively receiving federal contract awards, primarily from various National Institutes of Health (NIH) agencies and the Department of Veterans Affairs.

The company has consistently secured federal contract awards for highly specialized scientific services, predominantly involving the development of custom transgenic and knockout animal models. Specifically, Biocytogen Boston Corp has provided services such as creating knock-in mouse models, CRISPR knockout rat models, and specialized rat lines for research purposes. The federal contract awards have been firm fixed-price purchase orders ranging from $13,100 to $156,200, awarded by agencies including the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), National Cancer Institute (NCI), and Veterans Integrated Service Network 15 (VA - VHA VISN 15). These contracts support critical research initiatives in areas such as HIV transmission, alcoholism, drug abuse, and cancer research. None of the contracts included specific set-aside designations, and Biocytogen Boston Corp has operated as a prime contractor in these federal awards, delivering highly specialized scientific research services and genetically modified animal models to support advanced medical research.

Quick answers

What is Biocytogen Boston Corp's UEI?

Biocytogen Boston Corp's Unique Entity ID (UEI) in SAM.gov is SN23DNZQQTF9.

What is Biocytogen Boston Corp's CAGE code?

Biocytogen Boston Corp's CAGE code is 9FYY0.

What is Biocytogen Boston Corp's primary NAICS code?

Biocytogen Boston Corp's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Biocytogen Boston Corp located?

Biocytogen Boston Corp's physical address in SAM.gov is 300 3rd Ave FL 6, Waltham, MA 02451, USA.

Is Biocytogen Boston Corp registered in SAM.gov?

Yes. Biocytogen Boston Corp's SAM.gov registration is active through July 28, 2027.

What is Biocytogen Boston Corp's most recent federal award?

Biocytogen Boston Corp's most recent federal contract award is This firm fixed price purchase order is awarded for specialized knock-in mouse models to biocytogen boston… (75N94025P00385), from National Institute of Child Health and Human Development, on July 15, 2025.

On GovTribe

See Biocytogen Boston Corp's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors